Sign in to continue:

Wednesday, January 28th, 2026

Asian Stock Exchanges 2026 Outlook – HKEX, SGX, Bursa Malaysia Valuations, Growth & ESG Trends Explained

Broker Name: CGS International
Date of Report: December 9, 2025
Excerpt from CGS International report.

Report Summary

  • Asian exchanges (HKEX, SGX, Bursa) are experiencing diverging valuations amidst strong liquidity trends, with HKEX’s P/E premium to peers notably below its 10-year average, presenting an attractive entry point.
  • HKEX is expected to benefit from sustained Southbound inflows via Stock Connect and a strong pipeline of jumbo IPOs, with a robust earnings growth outlook and potential re-rating catalysts like global monetary easing and a strong IPO pipeline.
  • SGX is enjoying structural tailwinds from increased liquidity via the MAS’s Equity Market Development Programme and the continued rollout of derivatives, supporting sustainable revenue growth.
  • Bursa Malaysia is forecast to see a rebound in equity market activity in 2026 as tariff risks subside and economic reforms take hold, with expectations for higher profit growth and ROE expansion.
  • The sector is rated Overweight, with an Add rating on all three exchanges. Key risks include global economic slowdown, regulatory changes, and lower trading volumes.
  • ESG scores are highlighted, with SGX leading on governance, Bursa as an ESG enabler in Malaysia, and HKEX expected to improve its ESG rating after past controversy.
  • Financial forecasts show above-peer EPS growth for HKEX, moderate growth for SGX and Bursa, and stable to improving dividend yields across all three exchanges.

Above is an excerpt from a report by CGS International. Clients of CGS International can be the first to access the full report from the CGS International website: https://www.cgs-cimb.com

Suzhou Ribo Life Science IPO: Leading the Future of siRNA Oligonucleotide Therapeutics – Company Overview, Pipeline, and Competitive Edge 1116272278

Suzhou Ribo Life Science Co., Ltd. IPO: Investor Analysis & Outlook Suzhou Ribo Life Science Co., Ltd. Date of prospectus: December 31, 2025 Suzhou Ribo Life Science IPO: In-Depth Analysis, Investor Insights & Listing...

Early Uptrend Signals Strong Growth Potential for HKBN Ltd

Date: October 22, 2024Broker: CGS International Securities Overview of HKBN Ltd (1310) HKBN Ltd. provides a range of telephone voice and data communication services, including wireless internet services, IDD and IPTV services, local telephony,...

Hydropipes Berhad IPO: Tapping into Malaysia’s Booming Water Infrastructure Market

Hydropipes Berhad IPO: Hydropipes Berhad specializes in the fabrication of mild steel pipes and fittings, primarily serving the water reticulation industry. Industry Growth: The demand for water infrastructure projects in Malaysia has been increasing...